Description
Latin name
VELAFAX
Packing
30 pcs
Pharmacological action
Velafax – an antidepressant that does not chemically belong to any class of antidepressants (tricyclic, tetracyclic or others), is a racemate of two active enantomers. The mechanism of the antidepressant effect of the drug is associated with its ability to potentiate the transmission of a nerve impulse to the central nervous system.
Indications
Depression of various etiologies (treatment and prevention).
Special instructions
Cancellation of the drug Velafax: as with other antidepressants, abrupt cessation of venlafaxine therapy, especially after high doses of the drug, it can cause withdrawal symptoms, therefore it is recommended to gradually reduce the dose before discontinuing the drug. The duration of the period necessary to reduce the dose depends on its size, duration of therapy, as well as the individual sensitivity of the patient.
Dosage and Administration
Inside, with meals. The recommended initial daily dose of Velafax is 37.5 mg 2 times a day. If after several weeks of treatment there is no significant improvement, the dose can be increased to 150 mg per day – 75 mg 2 times a day.
Side effects
General symptoms: weakness, fatigue.
From the gastrointestinal tract: loss of appetite, constipation, nausea, vomiting, dry mouth, rarely hepatitis.
From the side of metabolism: increase in serum cholesterol, decrease in body weight, sometimes – change in the results of laboratory tests of liver function, hyponatremia, syndrome of insufficient secretion of antidiuretic hormone.
From the cardiovascular system: arterial hypertension, hyperemia of the skin, postural hypotension, tachycardia.
From the side of the central nervous system: unusual dreams, dizziness, insomnia, increased irritability, paresthesia, stupor, increased muscle tone, tremors, yawning sometimes – apathy, hallucinations, muscle cramps, serotonin syndrome, rarely – epileptic seizures, manic reactions, as well as symptoms, resembling malignant antipsychotic syndrome.
From the genitourinary system: disorders of ejaculation, erection, anorgasmia, dysuric disorders (mainly – difficulties at the beginning of urination) sometimes – decreased libido, menorrhagia, urinary retention.
On the part of the sensory organs: disturbances of accommodation, mydriasis, visual impairment infrequently – violation of taste sensations.
From the skin: sweating sometimes – photosensitivity reactions rarely – erythema multiforme, Stevens-Johnson syndrome.
From the hemopoietic system: sometimes – hemorrhages in the skin (ecchymosis) and mucous membranes, thrombocytopenia rarely – prolongation of bleeding time.
Storage conditions
Store in a dry, dark place at a temperature not exceeding 25C.
The Expiration of
is 3 years.
Active ingredient
Vein lafaxine
terms of sale from
pharmacies Prescription
Dosage form
tablet
Teva Pharmaceutical Enterprises Co., Ltd. Israel
